Physician profile
Jeffrey D Coats
NPI 1770995201
$5,298.29
in general payments reported to CMS, 2019-2025
23 companies · $1,196 in 2025
The $1,196 reported for 2025 was more than what 99% of Occupational Vision providers received nationally (typical 2025 total: $169).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $361 · 2020: $104 · 2021: $939 · 2022: $607 · 2023: $680 · 2024: $1,412 · 2025: $1,196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,269 · Entertainment: $18.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,268.96 |
| Entertainment | $18.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,131.75 | 2022-2025 | Infuse, Infuse Multifocal, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $869.65 | 2019-2021 | |
| Glaukos Corporation | $641.47 | 2021-2025 | Photrexa Viscous and Photrexa, Ce-Marked Kxla System |
| Coopervision INC. | $435.53 | 2019-2025 | Myday Contact Lens |
| Tarsus Pharmaceuticals, INC. | $368.86 | 2024-2025 | Xdemvy |
| Biotissue Holdings INC. | $319.09 | 2025 | |
| Alcon Vision LLC | $240.42 | 2022-2024 | Total30, Dailies Total1 |
| Dompe US, INC. | $158.34 | 2024 | Oxervate |
| Johnson & Johnson Vision Care, INC. | $155.41 | 2022-2025 | |
| Kala Pharmaceuticals, INC. | $107.72 | 2022 | |
| Optos, INC. | $107.42 | 2021-2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Maculogix, INC. | $102.44 | 2021 | |
| Abb Con-Cise Optical Group LLC | $102.32 | 2021-2024 | Spectacle Lenses, Contact Lens |
| Allergan, INC. | $99.39 | 2022 | |
| Topcon Healthcare, INC. | $88.39 | 2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $81.59 | 2024 | Iyuzeh |
| Carl Zeiss Meditec USA, INC. | $67.06 | 2023 | Clarus |
| Carl Zeiss Meditec, INC. | $52.13 | 2020-2024 | Cirrus Hd-Oct |
| Sight Sciences, INC. | $42.65 | 2024 | Tearcare System |
| Oyster Point Pharma, INC. | $41.79 | 2023-2024 | Tyrvaya, Ryzumvi |
| Mallinckrodt Hospital Products INC. | $32.61 | 2025 | Acthar |
| Sun Pharmaceutical Industries INC. | $31.62 | 2021 | |
| Abbvie INC. | $20.64 | 2023 | Vuity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Coats listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.